Department of Visceral Surgery, Lausanne University Hospital (CHUV), Rue du Bugnon 46, Lausanne, 1011, Switzerland.
Faculty of Biology and Medicine, University of Lausanne (UNIL), Lausanne, Switzerland.
Langenbecks Arch Surg. 2024 Nov 23;409(1):354. doi: 10.1007/s00423-024-03557-9.
Revisional bariatric surgery (RBS) has flourished during the last decades in many countries, due to suboptimal weight loss or long-term complications of primary bariatric surgery. Restrictive procedures, and in particular sleeve gastrectomy (SG), although widely performed as primary bariatric surgery, seems particularly prone to need surgical revision for the above-mentioned reasons during long-term follow-up. The aim of this systematic review was to compare the long-term (5-year) safety and efficacy between Roux-en-Y gastric bypass (RYGB) and single anastomosis duodeno-ileal bypass (SADI) after 'failed' SG.
A systematic review was performed from 2007 to September 2024. Articles were included if SADI or RYGB were performed as RBS after 'failed SG' with follow-up at least 5 years. Pooled analysis was performed to summarize the data.
Among the seven studies eligible and included in this review, the SADI procedure showed comparable results to RYGB in terms of weight loss, nutritional deficiencies, and resolution of comorbidities during the long-term follow-up. However, RYGB proved superior in terms of remission of reflux disease and other functional problems after SG.
The present review found that SADI seems to be a promising and suitable method for suboptimal weight loss after SG, with comparable or even better results to RYGB after 5-year follow-up.
由于初次减重手术的减重效果不理想或长期出现并发症,在过去几十年中,许多国家的减重手术翻修(RBS)蓬勃发展。限制型手术,特别是袖状胃切除术(SG),虽然广泛应用于初次减重手术,但在长期随访中,由于上述原因,似乎特别容易需要手术翻修。本系统评价的目的是比较 RYGB 和 SADI 在“失败”SG 后长期(5 年)的安全性和疗效。
从 2007 年到 2024 年 9 月进行了系统评价。如果 SADI 或 RYGB 作为 RBS 用于“失败的 SG”,并且随访时间至少为 5 年,则纳入研究。进行汇总分析以总结数据。
在本综述中纳入的七项研究中,在长期随访中,SADI 手术在减重、营养缺乏和并发症缓解方面与 RYGB 结果相当。然而,在 SG 后反流性疾病和其他功能问题的缓解方面,RYGB 证明更优越。
本综述发现,SADI 似乎是 SG 后体重减轻不理想的一种有前途且合适的方法,在 5 年随访后与 RYGB 结果相当,甚至更好。